tiprankstipranks

Current Stock - New Portfolio

MM

Current Stock
Individual Investor
Ranked #453,061 out of 858,800 TipRanks' Investors
Success Rate
52%
206 out of 393
profitable transactions
Average Return
1.83%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 41.69%
6-Month Return▼ 92.43%
12-Month Return▼ 94.33%
YTD Return▼ 77.27%
Total Return▼ 97.73%

Best Trade

Opened at
Closed at-
Gain▲ 1980.00%

Bio

This is my private investment portfolio...

Performance

41.59%0-41.59%
▲ 12.88%
▲ 3.56%
▼ 24.10%
Sep 2025
▲ 10.96%
▲ 2.38%
▼ 31.79%
Oct 2025
▼ 3.68%
▲ 0.19%
▼ 24.60%
Nov 2025
▼ 0.10%
▲ 0.08%
▼ 41.59%
Dec 2025
▲ 4.06%
▲ 1.47%
▼ 37.88%
Jan 2026
▼ 1.12%
▼ 0.86%
▼ 28.01%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 34.08%
Mar 2026
▲ 4.98%
▲ 4.55%
▼ 22.89%
Apr 2026
TipRanks AverageS&P 500Investor Portfolio
▲ 12.88%▲ 3.56%▼ 24.10%
▲ 10.96%▲ 2.38%▼ 31.79%
▼ 3.68%▲ 0.19%▼ 24.60%
▼ 0.10%▲ 0.08%▼ 41.59%
▲ 4.06%▲ 1.47%▼ 37.88%
▼ 1.12%▼ 0.86%▼ 28.01%
▲ 0.60%▼ 4.94%▼ 34.08%
▲ 4.98%▲ 4.55%▼ 22.89%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Iperionx Limited
▲ 7.64%
2
Close
Aug 13, 2025
Chilwa Minerals Ltd
▲ 19.88%
3
Close
Aug 13, 2025
Brazilian Rare Earths Ltd.
▼ 1.27%
2
Close
Aug 13, 2025
Milestone Pharmaceuticals
▲ 4.05%
4
Close
Aug 12, 2025
Autodesk
▼ 5.72%
4
Close
Aug 12, 2025
Super Micro Computer
▲ 51.34%
2
Close
Aug 12, 2025
AST SpaceMobile
▲ 128.15%
2
Close
Aug 12, 2025
Jasper Therapeutics
▼ 73.03%
3
Close
Aug 12, 2025
Verastem
▲ 41.22%
3
Close
Aug 12, 2025
Visa
▲ 9.99%
2
Close
Aug 12, 2025
Matador Resources
▼ 24.42%
2
Close
Aug 12, 2025
Arcutis Biotherapeutics
▲ 19.74%
2
Close
Aug 12, 2025
Centessa Pharmaceuticals
▼ 2.89%
2
Close
Aug 12, 2025
Solid Biosciences
▲ 39.81%
2
Close
Aug 12, 2025
IQE plc
▼ 4.02%
2
Close
Aug 12, 2025
Lightwave Logic
▲ 2.30%
2
Close
Aug 12, 2025
POET Technologies
0%
▲ 10.14%
1
Open
Aug 10, 2025
Tango Therapeutics
0%
▲ 222.93%
1
Open
Aug 10, 2025
Axsome Therapeutics
▲ 4.48%
6
Close
Jan 13, 2025
SkyWest
▼ 2.19%
3
Close
Jan 10, 2025